TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
$33.85
0.00%
(0.00) 1D
Oct 6, 11:51:40 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TKPHF...
Mkt. cap
59.62B
Avg. vol.
2.50K
Volume
0.00
52-wk high
$39.20
52-wk low
$26.33
Beta
-2.60
Shares outstanding
1.60B
No. of employees
47K
Mkt. cap
59.62B
Avg. vol.
2.50K
Volume
0.00
52-wk high
$39.20
52-wk low
$26.33
Beta
-2.60
Shares outstanding
1.60B
No. of employees
47K
News stories
From web sources and news partners
TipRanks
·
9 hours ago
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
AD HOC NEWS
·
11 hours ago
Takeda Pharmaceutical stock trades at EUR 16.55 with a P/ E of 52.1
AD HOC NEWS
·
19 hours ago
Takeda Pharmaceutical stock pre-market at EUR 16.55: unchanged
AD HOC NEWS
·
4 weeks ago
Takeda Pharmaceutical stock after-hours at EUR 16.55: unchanged
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com